Wilkins BS. The spleen. Br J Haematol. 2002;117:265-274.
Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics of tumours of haematopoietic and lymphoid tissues: IARC WHO classification of tumours, No. 3. Washington, DC: IARC Press WHO; 2009.
Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood. 2008;112:3939-3948.
Schechter AN. Hemoglobin research and the origins of molecular medicine. Blood. 2008;112:3927-3938.
1. Lichtin AE, Cook JR. Diseases of the spleen. In: Young NS, Gerson SL, High KA, eds. Clinical hematology. 1st ed. Philadelphia, PA: Elsevier; 2006:697-705.
2. Willner IR, Reuben A. Alcohol and the liver. Curr Opin Gastroenterol. 2005;21:323-330.
3. Advani R, Rosenberg SA, Horning SJ. Stage I and II follicular non-Hodgkin's lymphoma: long term follow-up of no initial therapy. J Clin Oncol. 2004;22:1454-1459.
4. Koc O, Wilson WH. Non-Hodgkin's lymphoma. In: Young NS, Gerson SL, High KA, eds. Clinical hematology. 1st ed. Philadelphia, PA: Elsevier; 2006:579-595.
5. Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. Blood. 2004;104:3009-3020.
6. Treon SP, Gertz MA, Dimopoulos M, et al. Update on treatment recommendations from the Third International Workshop on Waldenstrom's Macroglobulinemia. Blood. 2006;107:3442-3446.
7. Wilkins BS. The spleen. Br J Haematol. 2002;117:265-274.
8. Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics of tumours of haematopoietic and lymphoid tissues: IARC WHO classification of tumours, No. 3. Washington, DC: IARC Press WHO; 2009.
9. Rawstron AC, Bennett FL, O'Conner SJM, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med. 2008;359:575-583.
10. Cortes JE, Talpaz M, O'Brien S, et al. Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposal. Cancer. 2006;106:1306-1315.
11. Mughal TI, Goldman JM. Chronic myeloid leukemia: current status and controversies. Oncology. 2004;18:837-844.
12. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000;342:1255-1265.
13. Tefferi A. JAK2 mutations in polycythemia vera: molecular mechanisms and clinical applications. N Engl J Med. 2007;356:444-445.
14. Lachmann HJ, Goodman HJB, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356:2361-2371.
15. Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124-131.
16. Grabowski GA. Recent clinical progress in Gaucher disease. Curr Opin Pediatr. 2005;17:519-524.
17. Imrie J, Vijayaraghaven S, Whitehouse C, et al. Niemann-Pick disease type C in adults. J Inherit Metab Dis. 2002;25:491-500.
18. Griffith KS, Lewis LS, Mali S, et al. Treatment of malaria in the United States: a systematic review. JAMA. 2007;297:2264-2277.
19. Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood. 2008;112:3939-3948.
20. Schechter AN. Hemoglobin research and the origins of molecular medicine. Blood. 2008;112:3927-3938.
21. Kaushansky K. Lineage-specific hematopoietic growth factors. N Engl J Med. 2006;354:2034-2045.
22. Yung L, Linch D. Hodgkin's lymphoma. Lancet. 2003;361:943-951.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台